${loserAccounts} been merged into ${winnerAccount}.
A recent audit found these accounts to be duplicative. Addresses, order history and Q-global ordering for both accounts are now accessible via the ${winnerAccount} account. If something isn’t right, please contact us.
${loserAccounts} been merged into ${winnerAccount}.
A recent audit found these accounts to be duplicative. Addresses, qualified users, order history and Q-global ordering for both organizations are now accessible via the ${winnerAccount} account. If something isn’t right, contact us.
Blog
How do you stay up to date in your field? Our team of experts, authors, and specialists contribute regularly to our profession-specific blogs, keeping you informed of the latest industry trends, news, and innovations. Find your tribe and check back often, as new content is added weekly!
Tracking cognitive functioning remains a critical part of Alzheimer’s disease (AD) and dementia research. When used properly, COAs offer valuable insights into patients’ conditions, helping researchers track patients’ progress and assess a drug’s efficacy throughout clinical trials.
However, choosing suboptimal scales can be catastrophic for clinical research. The cognitive scales used in the majority of clinical trials for AD, for example, have been pivotal to the failure of 98% of Phase 2 and 3 clinical trials.
In this blog, we’ll discuss how COAs can make or break clinical trial outcomes and share how sponsors can select the optimal scales for their AD clinical research programs.
As social media use surges among youth, educators are grappling with the need to manage device disturbances — while acknowledging that technology use is embedded in education. Although educators embrace digital tools to help surface diverse viewpoints, boost engagement and save time, clear guidelines are necessary to keep students on task during the school day and promote digital responsibility.
As schools and districts aim to set consistent rules for device and social media usage, they should embrace a balanced approach that fosters a safe, supportive learning environment while minimizing distractions and risky behaviour. Here are five guidelines to consider.
The world today can be a tumultuous place for the younger generation, who are often bombarded with daunting visuals and discussions of global conflicts, the implications of climate change, and political division in their own community. A recent survey of over 10,000 Ontario students in grades 7 to 12 found that more than half are experiencing significant psychological distress—a figure that has doubled over the past decade.
Comorbidities are common in autism. Some data suggest that almost 78 percent of autistic children have at least one co-occurring condition (and nearly half of children have two or more). The likelihood of experiencing comorbidities increases with age.
Digital tools are at the forefront of autism screening. The potential to improve screening, reduce disparities in screening and intervention, provide information to develop appropriate interventions, and streamline care has made them a go-to resource for clinicians.
“Enhancing Autism Diagnosis and Care with Digital Tools,” the third episode of Pearson's podcast, featured an engaging conversation with Pearson assessment consultant Colleen Williams.
Williams shared her thoughts on the role of digital tools for reducing caregiver burden, how digital tools can support progress monitoring and changing needs across different environments and the benefits of digital scoring for accessing additional metrics that could be valuable in targeting interventions.
The conversation kicked off with a discussion of the benefits of digital tools. Williams shared her thoughts on their utility and accessibility, cost-effectiveness, time efficiency, and the ability to access real-time results through digital platforms like Q-global and Q-interactive.
Digital tools also offer the potential for long-term progress tracking that makes it easier for clinicians to offer valuable insights for continuous monitoring.
The benefits have been made possible as a result of the growing availability of digital assessments for autism that include:
ASRS (Autism Spectrum Rating Scales)
BASC-3 (Behavior Assessment System for Children - Third Edition)
WISC-V / WAIS-V (Wechsler Intelligence Scale for Children / Wechsler Adult Intelligence Scale - Fifth Edition)
Vineland-3 (Vineland Adaptive Behavior Scales - Third Edition)
Sensory Profile 2
Conners 4 (Conners Rating Scales)
With more assessments available, clinicians can choose digital tools that improve the accuracy, efficiency, and accessibility of autism assessments. Williams believes digital versions of performance-based tests like the WISC/WAIS can “engage children more effectively compared to traditional pencil-and-paper methods.”
Pearson includes step-by-step instructions with all of their assessments to ensure accurate administration and maintain fidelity in assessments. Clinicians can be assured that the tools have maximum benefit.
Williams also shared her thoughts on the advantages of digital scoring, noting, “All evaluations require various data points from different settings. Digital assessments allow for multiple modes of delivery, providing clinicians with the opportunity to compare scores across different platforms.”
“By comparing scores from different tools or delivery methods, clinicians may discover that a patient responds better to a digital platform or vice versa, helping tailor interventions for more effective outcomes,” she adds.
For more insights, listen to “Enhancing Autism Diagnosis and Care with Digital Tools,” the third episode in the podcast series, “Navigating Autism, Transforming Lives: The essential role of assessments.”
